Safety of T-DM1/Temozolomide for The Prevention of HER2-Breast Cancer Associated Brain Mets
December 11th 2021Alexandra S. Zimmer, MD, discusses the safety of the combination of the T-DM1 ado-trastuzumab emtansine and temozolomide, for the prevention of further brain metastases in patients with HER2-positive breast cancer with brain metastases.
Watch
Determining Racial Disparities Related to Acute Kidney Injury in NSCLC
December 8th 2021Nino Balanchivadze, MD, FACP, discusses the methods used in the retrospective analysis of KEYNOTE-189 study, to determine the differences in the rate of renal toxicity based on race in patients with non-squamous non-small cell lung cancer.
Watch
Next Steps After Trial of Entinostat for Advanced Breast Cancer
December 6th 2021Evanthia Roussos Torres, MD, PhD, discusses the follow-up research related to the phase 1 study of entinostat administered in combination with nivolumab and ipilimumab for the treatment of locally advanced, metastatic, unresectable, or HER2-negative breast cancer.
Watch